Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 4964   Home Print this page  Email this page Small font size Default font size Increase font size
COMMENTARY
Year : 2015  |  Volume : 32  |  Issue : 4  |  Page : 402-403

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis


Center for Infectious Diseases Research and Experimental therapeutics, Baylor Institute for Immunology Research, Dallas, Texas, and Department of Immunology, UT Southwestern Medical Center, Dallas, Texas, USA

Correspondence Address:
Shashikant Srivastava
Center for Infectious Diseases Research and Experimental therapeutics, Baylor Institute for Immunology Research, Dallas, Texas, and Department of Immunology, UT Southwestern Medical Center, Dallas, Texas
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 26180397

Rights and PermissionsRights and Permissions



[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1390    
    Printed6    
    Emailed0    
    PDF Downloaded237    
    Comments [Add]    

Recommend this journal